Bacteria expressing murine decoy-resistant IL18 mutein (DR18) induced robust CD8<sup>+</sup> T and NK cell-dependent immune responses leading to dramatic tumor control, extending survival, and curing a significant proportion of immune-competent mice with colorectal carcinoma and melanoma. This evidence concerns the gene CD8A and colorectal carcinoma.